Martin Moser;Christoph Bode;Sebastian Grundmann;Felix Hans;Franziska Bluhm
发明人:
Sebastian Grundmann,Martin Moser,Christoph Bode,Franziska Bluhm,Felix Hans
申请号：
US13511860
公开号：
US20120328686A1
申请日:
2010.11.18
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Disclosed is a pharmaceutical composition comprising a miRNA-100 molecule or an antagomir thereof or a variant thereof for use as a medicament for the positive or negative modulation of blood vessel growth and vascular inflammation wherein the miRNA-100 or the miRNA antagomir has a homology of at least 85% to any of SEQ ID NO:1, 2, 3 and/or 9.
